Sec forma s-1mef

Hancock Jaffe Laboratories, Inc. - ‘S-1MEF’ on 2/8/21 Registration Statement to Add Securities to a Prior Form S-1 Registration - Seq. 1 - Accession Number 0001493152-21-003009 - Filing - SEC

All exhibits filed with or incorporated by reference in the Registration Statement on Form S-1 (SEC File No. 333-251893) are incorporated by reference into, and shall be deemed a part of, this Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]: SEC Accession No. 0001104659-21-001664 Filing Date. 2021-01-06. This Registration Statement on Form S-1 is being filed with respect to the registration of $2,300,000 of additional units of Cuentas Inc. (the “Registrant”), including $300,000 of units that may be The registration fee is calculated in accordance with Rule 457 (a) under the Securities Act of 1933, as amended, based on the proposed maximum aggregate offering price. The registrant previously Jun 03, 2020 · S-1MEF Filing Date. 06/03/20. Document Date.

24.01.2021 Sec forma s-1mef

Registration of up to an additional 20% of securities for any offering registered on an S-1. Filing Group. Registration Statements. Company. Inozyme Pharma, Inc. ENSV ENSERVCO Corporation Registration of Additional Securities (up to 20%) (s-1mef) Approximate date of commencement of proposed sale to the public: As soon as practicable after the effective date of this Registration Statement. If any of the securities being registered on this form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check Aug 12, 2020 Dec 05, 2002 S-1MEF. SEC Filing Details. Document Details.

The Registrant previously registered securities having a proposed maximum aggregate offering price of $ 201,250,000 on its Registration Statement on Form S-1, as amended (File No. 333-251964),

Opendoor Technologies Inc. (Exact name of registrant as specified Jan 24, 2018 The registrant previously registered securities at an aggregate offering price not to exceed $243,529,398.00 on a Registration Statement on Form S-1 (File No. 333-238783), which was declared effective by the Securities and Exchange Commission on June 18, 2020. In accordance with Rule 462(b) under the Securities Act, an additional amount of Reliance Global Group, Inc. - ‘S-1MEF’ on 2/9/21 Registration Statement to Add Securities to a Prior Form S-1 Registration - Seq. 1 - Accession Number 0001493152-21-003033 - Filing - SEC S-1MEF SEC Filing Details. Document Details. Form.

The contents of the Registration Statement on Form S-1, as amended (File No. 333-251875), which was initially filed on January 4, 2021, and which was declared effective by the Securities and Exchange Commission on January 27, 2021, including the exhibits thereto, are hereby incorporated by reference into this Registration Statement.

ATHENE HOLDING LTD. (Exact name of registrant as specified in its charter) The Registrant previously registered securities at an aggregate offering price not to exceed $170,200,000 on a Registration Statement on Form S-1, as amended (File No. 333-239487), which was declared effective by the Securities and Exchange Commission on July 16, 2020. In accordance with Rule 462(b) under the Securities Act, an additional The SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings. F-10MEF: Registration pursuant to Securities Act Rule 462(b) of up to an additional 20% of securities for an offering that was registered on a Form F-10. F-3 : Registration statement for certain foreign private issuers offered pursuant to certain types of transactions.

2020-12-11 00:00:00. S-1MEF. Registration of Securities Addition.

Registration of up to an additional 20% of securities for any offering registered on an S-1. Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]: SEC Accession No. 0001104659-21-001664 Filing Date. 2021-01-06. Form S-1MEF Sana Biotechnology, Inc. Registration adding securities to prior Form S-1 registration [Rule 462(b)] SEC.report Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]: SEC Accession No. 0001193125-21-026161 Filing Date. 2021-02-02. Registration of Securities Addition.

Registration of up to an additional 20% of securities for any offering registered on an S-1. Apr 14, 2020 · Form. S-1MEF Filing Date. Apr 14, 2020. Apr 14, 2020. Form Description. Registration of up to an additional 20% of securities for any offering registered on an S-1. SECURITIES AND EXCHANGE COMMISSION.

Registration of up to an additional 20% of securities for any offering registered on an S-1. Salesforce Com Inc - IPO: ‘S-1MEF’ on 6/23/04 Registration Statement to Add Securities to a Prior Form S-1 Registration - Seq. 1 - Accession Number 0001193125-04-106833 - Filing - SEC If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☒ File No. 333-214588 Feb 05, 2020 · S-1MEF Filing Date. Feb 5, 2020. Document Date.

ako pridať peniaze na paypal účet
ako je na tom dolár dnes
rozdiel súkromného a verejného blockchainu
najlepšia aplikácia na výmenu kryptomien ios
previesť šek na debetnú kartu
libanonská libra na usd teraz

Represents only the additional amount of securities being registered. The registrant previously registered securities at an aggregate offering price not to exceed $8,050,000.00 on a Registration Statement on Form S-1 (File No. 333-252275), which was declared effective by the Securities and Exchange Commission on February 8, 2021.

Apr 14, 2020. Apr 14, 2020. Form Description. Registration of up to an additional 20% of securities for any offering registered on an S-1. SECURITIES AND EXCHANGE COMMISSION. WASHINGTON, D.C. 20549 . FORM S-1 . REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 .